Bank Of America Corp Cullinan Oncology, Inc. Transaction History

Bank Of America Corp

$1.19 Trillion
Q3 2024

A detailed history of Bank Of America Corp transactions in Cullinan Oncology, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 409,793 shares of CGEM stock, worth $5.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

409,793

Previous 412,745 0.72%

Holding current value

$5.14 Million

Previous $7.2 Million 4.71%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$16.03 - $20.86 $47,320 - $61,578	-2,952 Reduced 0.72%	409,793 $6.86 Million
Q2 2024 Aug 14, 2024	BUY	$15.63 - $29.35 $4.4 Million - $8.26 Million	281,396 Added 214.24%	412,745 $7.2 Million
Q1 2024 May 15, 2024	SELL	$10.17 - $19.02 $41,320 - $77,278	-4,063 Reduced 3.0%	131,349 $2.24 Million
Q4 2023 Feb 14, 2024	BUY	$7.89 - $10.23 $912,273 - $1.18 Million	115,624 Added 584.31%	135,412 $1.38 Million
Q2 2023 Aug 14, 2023	SELL	$8.8 - $13.4 $584,434 - $889,934	-66,413 Reduced 77.04%	19,788 $212,000
Q1 2023 May 12, 2023	BUY	$10.2 - $11.91 $166,994 - $194,990	16,372 Added 23.45%	86,201 $881,000
Q4 2022 Feb 10, 2023	BUY	$9.72 - $13.62 $67,359 - $94,386	6,930 Added 11.02%	69,829 $736,000
Q3 2022 Nov 14, 2022	BUY	$11.82 - $15.42 $404,563 - $527,780	34,227 Added 119.37%	62,899 $806,000
Q2 2022 Aug 12, 2022	SELL	$7.31 - $13.55 $122,522 - $227,111	-16,761 Reduced 36.89%	28,672 $367,000
Q1 2022 May 16, 2022	BUY	$10.47 - $16.75 $171,540 - $274,432	16,384 Added 56.4%	45,433 $475,000
Q4 2021 Feb 08, 2022	BUY	$15.36 - $25.0 $303,897 - $494,625	19,785 Added 213.57%	29,049 $448,000
Q3 2021 Nov 15, 2021	SELL	$22.56 - $29.68 $121,192 - $159,440	-5,372 Reduced 36.7%	9,264 $209,000
Q2 2021 Sep 13, 2021	BUY	$24.96 - $41.25 $365,314 - $603,735	14,636 New	14,636 $376,000

Others Institutions Holding CGEM

# of Institutions

146

Shares Held

67.6M

Call Options Held

612K

Put Options Held

118K

View Full List

About Cullinan Oncology, Inc.

Ticker CGEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,612,200
Market Cap $572M
Description
Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...

More about CGEM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Cullinan Oncology, Inc. Transaction History